REVOLADE - Medsafe
REVOLADE® NEW ZEALAND DATA SHEET rev270218iNZ Page 2 of 29 4.2 Dose and method of administration Dose (adults) REVOLADE dosing regimens must be …
Download REVOLADE - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
INJECTABLE MEDICATIONS FEE SCHEDULE ONCOLOGY …
ahca.myflorida.comcode description max qty rate comments/notes injectable medications fee schedule oncology 01/01/2018 j9151 daunorubicin citrate, liposomal formulation
Procedures, programs and drugs you must precertify
www.aetna.comProcedures, programs and drugs you must precertify Participating provider precertification list Starting November 1, 2018 Applies to 1,2,3,4,9
DRUG NAME: Interferon alfa-2b - BC Cancer
www.bccancer.bc.caThe table includes adverse events that presented during drug treatment but may not necessarily have a causal relationship with the drug. Because clinical trials …
An Analysis of the US Biosimilars Development Pipeline and ...
www.biopharma.com16 BioProcess International 11(6)s Ju n e 2013 Supplement N o consensus concerning biosimilar-related terminology and definitions has yet been achieved (1–3).Biosimilars may be defined as biopharmaceuticals slated for generic-
AGENTES INMUNO-MODULADORES (SUPRESORES y …
www.med-informatica.netViridiana García Ficha 11 Subtema 6 293 MUROMONAB: OKT3. IgG Alfa
Protocolo Clínico e Diretrizes Terapêuticas para o ...
www.sbhepatologia.org.brMINISTÉRIO DA SAÚDE Secretaria de Vigilância em Saúde Departamento de DST, Aids e Hepatites Virais Programa Nacional para a Prevenção e o Controle das
The Renal Drug Handbook - pharmalink.nl
www.pharmalink.nlThe Renal Drug Handbook Third EdiTion Edited by Caroline Ashley and Aileen Currie UK Renal Pharmacy Group Foreword by Dr Aine Burns radcliffe Publishing